Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2011

View Archived Issues

NK-012 shows promising activity in phase II trial in sensitive relapsed SCLC

MORAb-004 is active in first-in-human study

Allergan patents novel lysophospholipid S1P1 receptor modulators

New beta-secretase 2 inhibitors for diabetes patented by Roche

Novel AMPK activators synthesized

Compugen validates second candidate based on CD28/B7 costimulatory family

Randox launches automated H-FABP assay

SK Chemicals' new 11-beta-HSD1 inhibitor SKI-2852 is active in models of diabetes

RG-7112 advances through clinical development for cancer

Preliminary phase I data suggest safety/activity of RO-4987655 in advanced/metastatic solid tumors

PSN-821 reduces energy intake in patients with obesity and type 2 diabetes

Novartis patents new cytochrome P450 inhibitors

Novel arachidonic acid analogues prepared by Cytometix for use as analgesics

CHMP adopts positive opinion on Buccolam

Alzheimer's Drug Discovery Foundation supports Axxam research

Nile Therapeutics advances phase I trial of cenderitide for heart failure

Amgen obtains positive CHMP opinion on Vectibix after reexamination

Mimetogen reports promising phase II data on MIM-D3 in dry eye syndrome

EMA accepts tesamorelin MAA for review

Immunomedics receives third milestone payment related to veltuzumab development

Apeiron Biologics enters research alliance for neuroblastoma therapy CH-14.18

Banzel approved in Canada for seizures associated with Lennox-Gastaut syndrome

Jevtana/prednisone combination approved in Canada for prostate cancer

Evotec and Roche collaborate on protein-activity based biomarkers for use in oncology

ERYtech completes enrollment in phase I Graspa trial in pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...